RDD Blog » 2009 » March

R&D Directions Insider

Archive for March, 2009

High-risk views on chronic illness

Thursday, March 26th, 2009

If you happened to peruse yesterdayâ€™s fresh serving of health nuggets here at Pharmalive, you may have come across a rather unsettling new survey by the American Diabetes Association. The poll revealed that the majority of Americans are more afraid of developing chronic illnesses (heart disease, cancer, diabetes, HIV, Alzheimer's ...

Posted in Uncategorized | No Comments »

Stem cell promise â€˜substantialâ€™

Monday, March 23rd, 2009

Stem cell research is hot again. Many scientists and patients are rejoicing after President Obama recently removed the ban on human embryonic stem cell research. Hundreds of cell lines created since the ban was enacted almost eight years ago are now potentially free to be studied using federal grant money. ...

Posted in Uncategorized | No Comments »

Warning: may cure diabetes

Friday, March 20th, 2009

We've talked a lot about animals in our visit to Old MacDonald's Pharma, but there's some fascinating things going on out in the fields as well. According to Reuters, European scientists have discovered that breeding genetically modified tobacco plants containing interleukin-10 (IL-10) anti-inflammatory protein may help patients with type 1 diabetes ...

Posted in diabetes, molecular farming, plants | No Comments »

No borders on disease spread

Thursday, March 19th, 2009

TheÂ recession isnâ€™t the only reason infectious diseases are on the rise. According to an expert from theÂ World Health Organization, these diseases are becoming more prevalent due to unruly urbanization, governmentâ€™s failure to control mosquitoes, and greater air travel. Dengue, chikungunya, and other infectious diseases are killing more people worldwide. Last year, ...

Posted in infectious diseases, recession, vaccines | No Comments »

Hey, big spender

Friday, March 13th, 2009

These are indeed thrifty times, but donâ€™t tell that to your area pharmaceutical or biological developer. In case you missed it, a survey released this week revealed that R&D spending by U.S. biopharmaceutical companies reached a record $65.2 billion last year, despite the nationâ€™s economic slide. Remember, that figure reflects investment ...

Posted in Uncategorized | No Comments »

Recession may spread infectious diseases

Wednesday, March 11th, 2009

With the recession hitting the public health system even harder, budget cuts have left the system under funded by about $20 billion, and, according to some reports, experts are concerned that there are more than five exotic diseases that may become more common in the United States. According to MSNBC, the ...

Posted in infectious diseases, recession | No Comments »

Merging opinions abound

Wednesday, March 11th, 2009

As you can imagine, the consolidation frenzy in the biopharmaceutical industry is a hot topic at this year's R&D Directions Drug Development Summit. Opinions on whether the M&A trend, nearing yet another chapter any day now, is good or bad for the industry have varied. But one thing is clear, ...

Posted in Uncategorized | No Comments »

Drug summit day one

Tuesday, March 10th, 2009

Howdy from Arizona. Wow! What a first day. Not a second to spare, even for the loyal readers of the R&D blog. My apologies for not posting sooner, but after a busy first day of sessions at our Drug Development Summit in Phoenix, we were whisked away to Sunset Point, ...

Posted in Uncategorized | No Comments »

Growing movement toward independent contracting

Monday, March 9th, 2009

During these tough economic times, when employment opportunities are scarce, more people are looking to other forms of income, such as independent contracting. According to a recent survey conducted by Redtree People Ltd., 60% of clinical research personnel have considered becoming contractors in the past and over 84% said they ...

Posted in CRO, recession | No Comments »

Desert powwow

Monday, March 9th, 2009

R&D Directions is on location in the wild, wild West. Check back later today for my first blog installment from the magazine's annual Drug Development Summit, which this year is at the Wigwam resort in Phoenix. There are seven sessions on today's docket, with experts from the pharmaceutical ...

Posted in Uncategorized | No Comments »

©2012 UBM Canon